• J. Am. Acad. Dermatol. · Dec 2020

    Practice Guideline

    National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.

    • Joel M Gelfand, April W Armstrong, Stacie Bell, George L Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D Dommasch, Steve R Feldman, Dafna Gladman, Leon Kircik, Mark Lebwohl, Vincent Lo Re, George Martin, Joseph F Merola, Jose U Scher, Sergio Schwartzman, James R Treat, Abby S Van Voorhees, Christoph T Ellebrecht, Justine Fenner, Anthony Ocon, Maha N Syed, Erica J Weinstein, Jessica Smith, George Gondo, Sue Heydon, Samantha Koons, and Christopher T Ritchlin.
    • Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Joel.Gelfand@pennmedicine.upenn.edu.
    • J. Am. Acad. Dermatol. 2020 Dec 1; 83 (6): 1704-1716.

    ObjectiveTo provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic.Study DesignA task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care was convened. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation (NPF) staff. Clinical questions relevant to the psoriatic disease community were informed by questions received by the NPF. A Delphi process was conducted.ResultsThe TF approved 22 guidance statements. The average of the votes was within the category of agreement for all statements. All guidance statements proposed were recommended, 9 with high consensus and 13 with moderate consensus.LimitationsThe evidence behind many guidance statements is limited in quality.ConclusionThese statements provide guidance for the management of patients with psoriatic disease on topics ranging from how the disease and its treatments impact COVID-19 risk and outcome, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 and what they should do if they develop COVID-19. The guidance is intended to be a living document that will be updated by the TF as data emerge.Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…